April 25, 2007 12:50 PM
The modern pharmaceutical era was born in 1897 when the German chemist Felix Hoffman, an employee of Bayer Industries, synthesized acetylsalicylic acid, or aspirin, in the laboratory. For decades aspirin was one of the few non-narcotic analgesic choices that physicians and patients possessed for the relief of fever, pain and inflammation. While not perfectly safe, aspirin was practically devoid of the much more serious side effects associated with the use of narcotic analgesics.
April 25, 2007 12:48 PM
Celebrex Liability Overview
April 25, 2007 12:28 PM
OUTLINE Tort Law Update December 21, 1999
April 25, 2007 12:15 PM
OUTLINE Tort Law Update December 14, 1998
April 25, 2007 12:08 PM
No doubt, great trial lawyers are remembered most fondly by their closing arguments. The closing argument is the trial lawyer’s single opportunity for pure oratory in the trial process. By the time trial counsel rises to deliver his closing arguments, there is no longer an issue of a “burden of proof.” Instead, the concern is now focused on the “burden of persuasion.” However, it is a rare case that can be salvaged through even the most eloquent of closing arguments if the foundation or building blocks of persuasion have not been firmly established throughout the preceding stages of trial.